• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人肝硬化和肿瘤性肝组织中肝细胞生长因子(HGF)、其受体c-甲硫氨酸(c-met)、c- myc和白蛋白的表达

Expression of HGF, its receptor c-met, c-myc, and albumin in cirrhotic and neoplastic human liver tissue.

作者信息

Ljubimova J Y, Petrovic L M, Wilson S E, Geller S A, Demetriou A A

机构信息

Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA.

出版信息

J Histochem Cytochem. 1997 Jan;45(1):79-87. doi: 10.1177/002215549704500111.

DOI:10.1177/002215549704500111
PMID:9010472
Abstract

Hepatocellular carcinoma (HCC) is a common type of cancer, with approximately 260,000 new cases each year, and liver cirrhosis is generally considered a major predisposing factor for HCC. However, specific changes of gene expression in liver cirrhosis and HCC remain obscure. The expression of genes for hepatocyte growth factor (HGF), its receptor c-met proto-oncogene, c-myc proto-oncogene, and albumin was analyzed. Gene expression was studied by PCR in seven normal human livers, nine cases of hepatitis C cirrhosis, 12 cases of alcoholic cirrhosis, two cases of liver adenoma, and 12 cases of HCC. HGF and c-met protein were revealed by immunofluorescent staining. HGF mRNA was not expressed in normal livers but was detected in adenomas, in 80% of HCC, and in some cirrhoses. Paraffin-embedded and fresh-frozen tissue samples yielded similar results. Immunohistochemical data correlated with PCR results regarding the overexpression of the HGF/c-met system in HCC. Albumin gene expression was decreased in HCC vs normal livers, consistent with altered function of tumor hepatocytes. The elevated expression of the HGF/c-met system in HCC may play a role in tumor development and/or progression. Tissue localization studies of HGF and its receptor c-met protein support the existence of both autocrine and paracrine mechanisms of action of HGF in HCC vs only a paracrine mechanism in normal liver.

摘要

肝细胞癌(HCC)是一种常见的癌症类型,每年约有26万新发病例,肝硬化通常被认为是HCC的主要诱发因素。然而,肝硬化和HCC中基因表达的具体变化仍不清楚。分析了肝细胞生长因子(HGF)、其受体c-met原癌基因、c-myc原癌基因和白蛋白的基因表达。通过聚合酶链反应(PCR)研究了7例正常人类肝脏、9例丙型肝炎肝硬化、12例酒精性肝硬化、2例肝腺瘤和12例HCC中的基因表达。通过免疫荧光染色揭示HGF和c-met蛋白。HGF mRNA在正常肝脏中未表达,但在腺瘤、80%的HCC以及一些肝硬化中被检测到。石蜡包埋和新鲜冷冻的组织样本得出了相似的结果。免疫组化数据与PCR结果相关,表明HGF/c-met系统在HCC中过表达。与正常肝脏相比,HCC中白蛋白基因表达降低,这与肿瘤肝细胞功能改变一致。HCC中HGF/c-met系统的表达升高可能在肿瘤发生和/或进展中起作用。HGF及其受体c-met蛋白的组织定位研究支持HGF在HCC中存在自分泌和旁分泌作用机制,而在正常肝脏中仅存在旁分泌作用机制。

相似文献

1
Expression of HGF, its receptor c-met, c-myc, and albumin in cirrhotic and neoplastic human liver tissue.人肝硬化和肿瘤性肝组织中肝细胞生长因子(HGF)、其受体c-甲硫氨酸(c-met)、c- myc和白蛋白的表达
J Histochem Cytochem. 1997 Jan;45(1):79-87. doi: 10.1177/002215549704500111.
2
u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma.在人类肝细胞癌中,尿激酶型纤溶酶原激活剂(u-PA)和c-MET信使核糖核酸(mRNA)表达协同增强,而肝细胞生长因子mRNA表达下调。
Int J Cancer. 2000 Sep 1;87(5):644-9.
3
Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma.肝细胞生长因子及其受体c-met原癌基因在肝细胞癌中的表达
Hepatology. 1997 Apr;25(4):862-6. doi: 10.1002/hep.510250413.
4
Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis.在肝癌发生过程中 MUC1 与 HGF/c-Met 通路的协同相互作用。
Mol Cancer. 2012 Sep 11;11:64. doi: 10.1186/1476-4598-11-64.
5
[Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].肝细胞生长因子和c-met对肝细胞癌患者的预后价值研究
Zhonghua Wai Ke Za Zhi. 2006 May 1;44(9):603-8.
6
HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.肝细胞癌、纤维板层样变体、肝硬化和正常肝脏中的肝细胞生长因子、间质-上皮转化因子及基质相关蛋白酶
Mod Pathol. 2003 Jan;16(1):14-21. doi: 10.1097/01.MP.0000043521.96995.DB.
7
Hepatocyte growth factor and c-met expression in Long-Evans Cinnamon rats with spontaneous hepatitis and hepatoma.肝细胞生长因子和c-met在患有自发性肝炎和肝癌的Long-Evans肉桂大鼠中的表达
Hepatology. 1996 Sep;24(3):596-602. doi: 10.1002/hep.510240323.
8
Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma.肝细胞生长因子及其受体c-met原癌基因在肝细胞癌中的表达。
Hepatology. 1997 Mar;25(3):619-23. doi: 10.1002/hep.510250321.
9
Relationship between the proliferative capability of hepatocytes and the intrahepatic expression of hepatocyte growth factor and c-Met in the course of cirrhosis development in rats.大鼠肝硬化发展过程中肝细胞增殖能力与肝细胞生长因子及c-Met肝内表达的关系
Int J Mol Med. 2006 May;17(5):857-64.
10
Gene expressions of c-met and hepatocyte growth factor in chronic liver disease and hepatocellular carcinoma.
J Hepatol. 1996 Mar;24(3):286-92. doi: 10.1016/s0168-8278(96)80006-7.

引用本文的文献

1
Alpha-fetoprotein and albumin inversely relate to each other and to tumor parameters in patients with hepatocellular carcinoma.在肝细胞癌患者中,甲胎蛋白和白蛋白相互呈负相关,且与肿瘤参数也呈负相关。
Hepatol Forum. 2024 Jan 16;5(1):11-17. doi: 10.14744/hf.2023.2023.0023. eCollection 2024.
2
Age independent survival benefit for patients with small hepatocellular carcinoma undergoing percutaneous cryoablation: A propensity scores matching study.小肝细胞癌患者接受经皮冷冻消融的年龄无关生存获益:一项倾向评分匹配研究。
Front Oncol. 2023 Jan 20;13:1072054. doi: 10.3389/fonc.2023.1072054. eCollection 2023.
3
Cytokines and Hepatocellular Carcinoma: Biomarkers of a Deadly Embrace.
细胞因子与肝细胞癌:致命关联的生物标志物
J Pers Med. 2022 Dec 20;13(1):5. doi: 10.3390/jpm13010005.
4
A Comparative Study of Serum Angiogenic Biomarkers in Cirrhosis and Hepatocellular Carcinoma.肝硬化和肝细胞癌血清血管生成生物标志物的比较研究
Cancers (Basel). 2021 Dec 21;14(1):11. doi: 10.3390/cancers14010011.
5
The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma.纤维化和肝相关成纤维细胞在肝细胞癌发病机制中的作用。
Int J Mol Sci. 2019 Apr 7;20(7):1723. doi: 10.3390/ijms20071723.
6
The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer.癌症相关成纤维细胞和纤维化在肝癌中的作用
Annu Rev Pathol. 2017 Jan 24;12:153-186. doi: 10.1146/annurev-pathol-052016-100322. Epub 2016 Dec 5.
7
Impact of MET targeting on tumor-associated angiogenesis and growth of MET mutations-driven models of liver cancer.MET靶向对肿瘤相关血管生成及MET突变驱动的肝癌模型生长的影响
Genes Cancer. 2015 Jul;6(7-8):317-327. doi: 10.18632/genesandcancer.74.
8
Sorafenib and DE605, a novel c-Met inhibitor, synergistically suppress hepatocellular carcinoma.索拉非尼和新型c-Met抑制剂DE605协同抑制肝细胞癌。
Oncotarget. 2015 May 20;6(14):12340-56. doi: 10.18632/oncotarget.3656.
9
Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors.肿瘤学中新兴的分子靶点:MET/肝细胞生长因子抑制剂的临床潜力
Onco Targets Ther. 2014 Jun 12;7:1001-14. doi: 10.2147/OTT.S44941. eCollection 2014.
10
Development of systemic therapy for hepatocellular carcinoma at 2013: updates and insights.2013年肝细胞癌全身治疗的进展:最新情况与见解
World J Gastroenterol. 2014 Mar 28;20(12):3135-45. doi: 10.3748/wjg.v20.i12.3135.